NCT05127590 2023-07-03RBN-2397 in Combination With Pembrolizumab in Patients With SCCLRibon Therapeutics, Inc.Phase 1/2 Unknown50 enrolled
NCT05718167 2023-02-14TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 Unknown570 enrolled